SOPHiA GENETICS SA (SOPH) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 0

One insider bought $99K, 2 sold $42K.

SellKevin Puylaert$1KChief Sales Officerat $8.06 on Oct 5, filed Oct 7

SellKevin PuylaertChief Sales Officer$1Kat $8.06 on Oct 5, filed Oct 7

SellKevin Puylaert$245.52Chief Sales Officerat $7.92 on Oct 5, filed Oct 7

SellKevin PuylaertChief Sales Officer$245.52at $7.92 on Oct 5, filed Oct 7

SellPhilippe Menu$39KChief Medical Officerat $7.88 on Sep 14, filed Sep 16

SellPhilippe MenuChief Medical Officer$39Kat $7.88 on Sep 14, filed Sep 16

From SEC Form 4s, the newest filed Oct 7, 2026 · Insiders have 2 business days to file a trade

5 more filings on SOPH in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 8 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on SOPH with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at SOPHiA GENETICS SA

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about SOPH's insider trades

As of Nov 2, 2026: SOPHiA GENETICS SA (SOPH) has 8 insider filings on record in the last 6 months, the newest filed Oct 7, 2026. Its Quality Score is 0 (Below Average). Scores as of 5:50 PM ET, 15 minutes behind.

Are SOPH insiders buying or selling?

One insider bought $99K across 1 filing, and 2 insiders sold $42K across 7 filings, in the last 6 months. The newest filing: Kevin Puylaert, Chief Sales Officer, sold $1K on Oct 5, 2026.

Who are SOPH's biggest insider sellers?

By the dollars of their sales in the last 6 months: Philippe Menu (Chief Medical Officer), 1 sale; Kevin Puylaert (Chief Sales Officer), 6 sales.

When did an SOPH insider last buy?

George Cardoza, Chief Financial Officer, bought SOPH shares on Jun 5, 2026, the newest insider buy on record.

SOPHiA GENETICS SA's page has its Quality Score, its chart, and its earnings. More in Healthcare and Software.